Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly And Co

Recent news which mentions Eli Lilly And Co

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Watch now: ETF Edge on reshoring trends, weight loss drugs and more
Tags Investment strategy Amgen Inc US: News
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Biotech and Pharmaceuticals Gilead Sciences Inc Oracle Corp
From CNBC.com News
Jim Cramer's top picks for pet-centric stocks
Tags Stock markets Business News Mad Money
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags China Economy Biotechnology Novo Nordisk A/S
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags Health care industry Novo Nordisk A/S Biotechnology
From CNBC.com News
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year
Tags Business US: News Companies
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Breaking News: Markets Europe News Zealand Pharma A/S
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Health care industry Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Biotech and Pharmaceuticals Health & Science Eli Lilly and Co
From CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
Tags Stock markets Business News Eisai Co Ltd
From CNBC.com News
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
Tags Companies Business US: News
From CNBC.com News
Jim Cramer's week ahead: Fed meeting and CPI report
Tickers RH
Tags Broadcom Inc RH U/S/ Markets
From CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Tags Merck & Co Inc Moderna Inc Pfizer Inc
From CNBC.com News
Alphabet's new CFO was in the middle of the GLP-1 boom. Now she's onto generative AI
Tags Internet Eli Lilly and Co Pharmaceuticals
From CNBC.com News
Alphabet taps Eli Lilly's Anat Ashkenazi as new CFO
Tags Breaking News: Technology Alphabet Inc Technology
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Employee benefits Small Business Labor economy
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Business News Pharmaceuticals Health care industry
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Biotech and Pharmaceuticals Exchange/traded funds ETF Edge
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Health care industry Internet Novo Nordisk A/S
From CNBC.com News
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
Tags Pharmaceuticals Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Cramer's Lightning Round: Sigma Lithium is 'too dicey'
Tags Sony Group Corp Eli Lilly and Co Market Outlook
From CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
Tags Investment strategy Pharmaceuticals Investing
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Healthy Returns Uber Technologies Inc Health & Science
From CNBC.com News
Roche says weight loss drug shows promising results in early trial
Tags Business US: News Roche Holding AG
From CNBC.com News
Healthy Returns: One in eight adults have taken Ozempic or other GLP-1s, survey says
Tags Science Health & Science Biotech and Pharmaceuticals
From CNBC.com News
People on Novo Nordisk's Wegovy maintain weight loss for up to four years, study says
Tags Business US: News Social issues
From CNBC.com News
Google's Demis Hassabis is the man tasked with turning bleeding-edge AI research into profits
Tags Breaking News: Technology Technology Tesla Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk make progress toward boosting weight loss drug supply
Tags Healthy Returns Health & Science Biotech and Pharmaceuticals
From CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
Tags Viking Therapeutics Inc Business News Biotechnology
From CNBC.com News
Within a few years, generative AI will be designing new drugs all on its own
Tags Eli Lilly and Co Drugs Pharmaceuticals
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.